Nanomedicine

Papers
(The H4-Index of Nanomedicine is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Intranasal Administration of Molecular-Gated Mesoporous Nanoparticles to Increase Ponatinib Delivery to The Brain222
Nanoparticles Integrated with Mild Photothermal Therapy and Oxaliplatin for Tumor cHemotherapy and Immunotherapy66
Multimodal Molecular Imaging in the Second Near-Infrared Window46
Considering the impact of the chirality of therapeutic nanoparticles on cancer therapy42
To heat or not to heat: the impact of temperature on the aggregation state of amphotericin B in drug delivery systems42
Simultaneous Multicolor Imaging of Lymph Node Chains Using Hydroporphyrin-Doped Near-Infrared-Emitting Polymer Dots39
Limitations of Limulus amebocyte lysate test for endotoxin control in raw materials for liposomal nanoformulations36
Enhanced Permeability and Retention Effect-Focused Tumor-Targeted Nanomedicines: Latest Trends, Obstacles and Future Perspective36
Cancer targeting carfilzomib nanomedicine: a comprehensive review of delivery vehicles and efficacy35
Advances in cancer nanovaccines: a focus on colorectal cancer34
Scaffold Biomaterials and Nano-Based Therapeutic Strategies for Skeletal Muscle Regeneration32
Nanobiotechnologies for stroke treatment29
Decitabine enclosed biotin-zein conjugated nanoparticles: synthesis, characterization, in vitro and in vivo evaluation29
Therapeutic Outcome of Quercetin Nanoparticles on Cerastes Cerastes Venom-Induced Hepatorenal Toxicity: A Preclinical Study27
Polyol-modified deformable liposomes fortified contact lenses for improved ocular permeability27
Insights Into the Mapping of Green Synthesis Conditions for Zno Nanoparticles and their Toxicokinetics27
Assessing the efficacy of nanoparticles in reversing opioid poisoning and preventing renarcotization27
Statement of Retraction: Tetraiodothyroacetic acid-conjugated PLGA nanoparticles: a nanomedicine approach to treat drug-resistant breast cancer27
Current views and trends of nanomaterials as vectors for gene delivery since the 21st century: a bibliometric analysis26
Immunogenicity of trivalent DNA vaccine candidate encapsulated in Chitosan-TPP nanoparticles against EV-A71 and CV-A1626
Nanotechnology-Based Mucoadhesive and Mucus-Penetrating Drug-Delivery Systems for Transbuccal Drug Delivery25
Intraductal Delivery of Nanocarriers for Ductal Carcinoma In Situ Treatment: A Strategy to Enhance Localized Delivery25
Development and characterization of multifunctional dendrimeric nanoconjugates for delivery of rutin: in vitro characterization for potential neuroprotec25
Antitumoral melatonin-loaded nanostructured lipid carriers25
Human Solid Tumors and Clinical Relevance of The Enhanced Permeation and Retention Effect: A ‘Golden Gate’ for Nanomedicine in Preclinical Studies?24
Nanotechnology in Adjuvants and Vaccine Development: What Should We Know?24
0.20020484924316